Market Overview

UBS Maintains Buy on BioMarin Pharmaceutical Inc., Raises PT to $67.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for BMRN

DateFirmActionFromTo
Apr 2016JefferiesMaintainsBuy
Apr 2016BMO CapitalInitiates Coverage onOutperform
Mar 2016Credit SuisseMaintainsOutperform

View More Analyst Ratings for BMRN
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (BMRN)